{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06148623",
            "orgStudyIdInfo": {
                "id": "CIP-1088"
            },
            "organization": {
                "fullName": "Masimo Corporation",
                "class": "INDUSTRY"
            },
            "briefTitle": "Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation",
            "officialTitle": "Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation",
            "therapeuticArea": [
                "Other"
            ],
            "study": "clinical-performance-testing-of-philips-fast-with-masimo-pulse-oximetry-sensors-across-skin-pigmentation"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-20",
            "studyFirstSubmitQcDate": "2023-11-20",
            "studyFirstPostDateStruct": {
                "date": "2023-11-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Masimo Corporation",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "Validate the performance of Philips FAST SpO2 with Masimo Pulse Oximetry Sensors in determining functional arterial oxygen saturation (SpO2) using arterial saturation (SaO2) as a reference in the range of 70-100% in subjects of varying skin pigmentation."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Test Subject",
                    "type": "EXPERIMENTAL",
                    "description": "All subjects who are enrolled into the test group and participate in data collection have the Philips FAST SpO2 with Masimo Pulse Oximetry Sensors",
                    "interventionNames": [
                        "Device: Philips FAST SpO2 with Masimo Pulse Oximetry Sensors"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Philips FAST SpO2 with Masimo Pulse Oximetry Sensors",
                    "description": "Noninvasive pulse oximeter",
                    "armGroupLabels": [
                        "Test Subject"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Oxygen saturation performance of Philips FAST SpO2 with Masimo pulse oximetry sensors",
                    "description": "Performance will be determined by calculating the average root mean square (ARMS) comparing the noninvasive oxygen saturation measurement (SpO2) to the arterial oxygen saturation (SaO2) value obtained from a reference blood sample.",
                    "timeFrame": "1-3 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Difference in oxygen saturation performance between three population subgroups",
                    "description": "Average root mean square (ARMS) will be computed for each pigmentation subgroup for light, medium, and dark skin pigmentation and the difference between the subgroup ARMS will be calculated.",
                    "timeFrame": "1-3 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria (Eligible Subjects):\n\n* Subject is 18 to 50 years of age.\n* Subject weighs a minimum of 110 lbs.\n* Baseline heart rate \u2265 45 bpm and \u2264 90 bpm.\n* Blood Pressure: Systolic BP \u2264 140 mmHg and \u2265 90 mmHg, Diastolic BP \u2264 90 mmHg and \u2265 50 mmHg, and if systolic BP is lower than 100 mmHg and/or diastolic BP is lower than 60 mmHg, subject passes an orthostatic blood pressure test.\n* Hemoglobin value \u2265 11 g/dL.\n* CO value \u2264 3.0% FCOHb.\n* Subject can read and communicate in English and understands the study and the risks involved.\n\nExclusion Criteria (Ineligible Subjects) (\\* = per clinician discretion):\n\n* Subject is pregnant or breastfeeding.\n* Subject has a BMI \\> 35.\n* Subject has a history of fainting (vasovagal syncope), blacking out or losing consciousness during or after a blood draw, or has a fear of blood draws.\n* Subject has open wounds, inflamed tattoos, or piercings, and/or has any visible healing wounds that a medical professional determines may place them at an increased risk for participation. \\*\n* Subject has finger deformities, nail deformities, nail polish, and/or gel/acrylic that can interfere with study device placement. \\*\n* Subject has known drug or alcohol abuse.\n* Subject uses recreational drugs. \\*\n* Subject experiences frequent or severe headaches and/or migraine headaches, migraine auras, altitude sickness, and/or headaches accompanied by visual changes or sensitivity to light or sound.\n* Subject has experienced a concussion or head injury with loss of consciousness within the past 12 months.\n* Subject has any history of a stroke, myocardial infarction (heart attack), and/or seizures.\n* Subject has any chronic bleeding disorder (e.g., hemophilia).\n* Subject has taken anticoagulant medication within the past 30 days (excluding nonsteroidal anti-inflammatory drugs (NSAIDs)).\n* Subject has donated blood within the past 4 weeks.\n* Subject has any cardiac dysrhythmia (e.g., atrial fibrillation) and has not received clearance from their physician to participate.\n* Subject has a known neurological and/or psychiatric disorder (e.g., schizophrenia, bipolar disorder, Multiple Sclerosis, Huntington's disease) that interferes with the subject's level of consciousness. \\*\n* Subject has taken opioid pain medication 24 hours before the study.\n* Subject has any infectious disease (e.g., Hepatitis, HIV, Tuberculosis, Flu, Malaria, Measles). \\*\n* Subject is taking medications known to treat any type of infectious disease.\n* Subject has either signs or history of peripheral ischemia or carpal tunnel syndrome.\n* Subject has had invasive surgery within the past year, including but not limited to major dental surgery, appendectomy, plastic surgery, jaw surgery, major ENT surgery, major abdominal and/or pelvic surgery, heart surgery, or thoracic surgery. \\*\n* Subject has symptoms of congestion, head cold, or other illnesses.\n* Subject has been in a severe car accident(s) or a similar type of accident(s) requiring hospitalization within the past 12 months.\n* Subject has any cancer or history of cancer (not including skin cancer). \\*\n* Subject has chronic unresolved asthma, lung disease (including COPD) and/or respiratory disease.\n* Subject is allergic to lidocaine, chlorhexidine, latex, adhesives, or plastic.\n* Subject has a heart condition, insulin-dependent diabetes, uncontrolled hypertension, or hypercholesterolemia.\n* Subject delivered vaginally, had a pregnancy terminated, had a miscarriage with hospitalization, or had a C-section within the past 6 months.\n* Subject intends on participating in any heavy lifting, repetitive movement of their wrist (including riding a motorcycle, tennis), exercise (e.g., working out, riding a bike, riding a skateboard), or any activity that will put additional stress on the wrist within 24 hours following a study that involves an arterial line.\n* Difficulty inserting an intravenous line in the subject's hand or arm and/or an arterial line in the radial artery of the subject's wrist.\n* Subject has any medical condition which in the judgment of the investigator and/or medical staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ahmed Alghazi",
                    "role": "CONTACT",
                    "phone": "949-297-7437",
                    "email": "aalghazi@masimo.com"
                }
            ],
            "locations": [
                {
                    "facility": "Masimo Corporation",
                    "status": "RECRUITING",
                    "city": "Irvine",
                    "state": "California",
                    "zip": "92618",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ahmed Alghazi",
                            "role": "CONTACT",
                            "phone": "949-297-7437",
                            "email": "aalghazi@masimo.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.66946,
                        "lon": -117.82311
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}